| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |